Skip to content

Measuring the degree of venous dilatation based on changes in avascular blood pressure and avascularization time

Measuring the degree of venous dilatation based on changes in avascular blood pressure and avascularization time - Degree of venous dilatation due to changes in avascular conditions

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052516
Enrollment
30
Registered
2023-10-17
Start date
2023-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing oral and oral surgery surgery under general anesthesia

Interventions

Blood aversion with mean blood pressure + pulse pressure Blood aversion at average blood pressure Blood abolition at the pressure of mean blood pressure - pulse pressure/2

Sponsors

Asahi General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing minor dental surgery (surgeries within 4 hours, such as wisdom tooth extraction, jawbone cyst removal, and benign tumor removal) at our dental/oral and oral surgery department. In addition, patients who meet all of the following conditions will be targeted. 1) Target patient age: 20-39 years old 2) Gender: Regardless of gender 3) Past medical history/severity of comorbidities: Those who have been evaluated as Class I or II in the Physical status (ASA-PS classification) defined by the American Society of Anesthesiologists (ASA). 4) Inpatient/Outpatient: All inpatient cases. To check if there are any effects from postoperative studies. 5) Surgery/anesthesia: Surgery completed as planned without requiring blood transfusion due to heavy bleeding. 6)Patients who have received sufficient explanation and informed written consent of their own free will to participate in this study.

Exclusion criteria

Exclusion criteria: 1) Past medical history: Those who have been diagnosed with hypertension, blood disease, hyperlipidemia, or heart disease, whether present or in the past. 2) Oral medications: Those using antihypertensive drugs, blood flow improving drugs, ischemic heart disease treatment drugs, antiplatelet drugs, and anticoagulants. (Patients who had previously stopped taking medication for this surgery are also considered to be on medication) 3) Conditions of the upper arm: Conditions in which it is difficult to avascularize the upper arm. 4) Surgery time: Surgery time exceeds 4 hours. 5) Surgery/anesthesia: Surgery that differed from the planned procedure and required blood transfusion due to massive bleeding. 6) Other patients deemed unsuitable as research subjects by the research director (co-investigator)

Design outcomes

Primary

MeasureTime frame
Vein cross-sectional area

Countries

Japan

Contacts

Public ContactYukii Kojima

Asahi General Hospital Department of Anesthesiology

cojicoji1109@gmail.com0479638111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026